Kinetic, thermodynamic and statistical studies on the inhibition of adenosine deaminase by aspirin and diclofenac

References

• Frick L, Wolfenden R, Smal E, Baker DC. Transition-state stabilization by adenosine deaminase: Structural studies of its inhibitory complex with deoxycoformycin. Biochemistry 1986; 8: 1616–1621
   Web of Science ®Google Scholar
• Wilson DK, Rudolph FB, Quiocho FA. Atomic structure of adenosine deaminase complexed with a transition-state analog: Understanding catalysis and immunodeficiency mutations. Science 1991; 252: 1278–1284
   PubMed Web of Science ®Google Scholar
• Chechik BE, Schreder WP, Minowada J. An immunomorphological study of adenosine deaminase. distribution in human thymus tissue, normal lymphocytes, and hematopoietic cell lines. J Immunol 1981; 126: 1003–1007
   PubMed Web of Science ®Google Scholar
• Herschfeld MS, Mitchell BS. The metabolic and molecular basis of inherited disease, CR Scriver, AL Beaudet, WS Sly, D Valle. McGraw-Hill, New York 1995; 1725–1768
   Google Scholar
• Herschfield MS. Adenosine deaminase deficiency: clinical expression, molecular basis and therapy. Semin Hematol 1998; 35: 291–298
   PubMed Web of Science ®Google Scholar
• Gan TE, Dadonna PE, Mitchell BS. Genetic expression of adenosine deaminase in human lymphoid malignancies. Blood 1987; 69: 1376–1380
   PubMed Web of Science ®Google Scholar
• Hong L, Mulholland J, Chinsky JM, Knudsen TB, Kellems KE, Glasser SR:. Developmental expression of adenosine deaminase during decidualization in the rat uterus. Biol Reprod 1991; 44: 83–93
   PubMed Web of Science ®Google Scholar
• Phillis JW, Wu PH. The role of adenosine and its nucleotides in central synaptic transmission. Biol Reprod Prog Neurobiol 1981; 16: 187–239
   PubMed Web of Science ®Google Scholar
• Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994; 76: 5–13
   PubMed Web of Science ®Google Scholar
• Ohta A, Sitkovsky M. Critical Role of G protein-coupled adenosine Receptors in Down Regulation of Inflammation and Prevention of Tissue Damage In Vivo Nature 2001; 414: 916–920
   Google Scholar
• Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Neuroprotective role of adenosine in cerebral ischemia Trends. Pharmacol Sci 1992; 13: 439–445
   PubMed Web of Science ®Google Scholar
• Marquardt DL, Gruber HE, Wasserman SI. Adenosine release from stimulated mast cells. Proc Natl Acad Sci 1984; 81: 6192–6196, U.S.A.
   PubMed Web of Science ®Google Scholar
• Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C. Direct association of adenosine deaminase with aT cell activation antigen, CD26. Science 1993; 261: 466–469
   PubMed Web of Science ®Google Scholar
• Franco R, Valenzuela A, Lluis C, Blanco J. Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol Rev 1998; 161: 27–42
   PubMed Web of Science ®Google Scholar
• Baker DC, Hanvey JC, Hawkins LD, Murphy J. Identification of the bioactive enantiomer of. erythro-3-(adenine-9-yl)-2-nonanol, (EHNA), a semi-tight binding inhibitor of. adenosine deaminase. Biochem Pharmacol 1981; 30: 1159–1160
   PubMed Web of Science ®Google Scholar
• Agerwal RP, Spector T, Parks RE. Inhibition of adenosine deaminases by various inhibitors Biochem. Pharmacol 1977; 26: 359–367
   Web of Science ®Google Scholar
• Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. Adenosine deaminase: functional implications and different classes of inhibitors Med. Res Rev 2001; 21: 105–128
   Google Scholar
• McConnell WR, Furner RL, Hill DL. Pharmokinetics of 2’-deoxycoformycin in normal and L1210 leukemic mice drug metab. Dispos 1979; 7: 11–13
   PubMed Web of Science ®Google Scholar
• McConnell WR, El-Dareer SM, Hill DL. Metabolism and disposition of erythro-9-(2-hydroxy-3-nonyl)[14C]adenine in the rhesus monkey drug metab. Dispos 1980; 8: 5–7
   PubMed Web of Science ®Google Scholar
• Brogden RN, Sorkin EM. Pentostatin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders. Drugs 1993; 46: 652–677
   PubMed Web of Science ®Google Scholar
• Rafel M, Cervantes F, Beltran JM, Zuazu J, Nieto LH, Rayon C, Talavera JG, Montserrat E. Deoxycoformycin in the treatment of patients with hairy cell leukemia. Cancer 2000; 88: 352–357
   PubMed Web of Science ®Google Scholar
• Warner TD, Giuliano F, Vojnovici I, Bukasa A, Mitchell JA. Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci USA 1999; 96: 7563–7568
   PubMed Web of Science ®Google Scholar
• Cronstein BN. Molecular and cellular basis of inflammation, CN Serhan, PA Ward. Humana, Totowa, NJ 1998; 259–274
   Google Scholar
• Saboury AA, Divsalar A, Ataie G, Moosavi-Movahedi AA, Housaindokht MR, Hakimelahi GH. A product inhibition study on adenosine deaminase by spectroscopy and calorimetry. J Biochem Mol Biol 2002; 35: 302–305
   PubMedGoogle Scholar
• Saboury AA, Divsalar A, Ataie G, Amanlou M, Moosavi-Movahedi AA. Inhibition study of adenosine deaminase by caffeine using spectroscopy and isothermal titration calorimetry. Acta Biochemica Polinica 2003; 50: 849–855
   PubMed Web of Science ®Google Scholar
• Saboury AA, Bagheri S, Ataie G, Amanlou M, Moosavi-Movahedi AA, Hakimelahi GH, Cristalli G, S. Binding properties of adenosine deaminase interacted with theophylline. Chem Pharm Bull 2004; 52: 1179–1182
   PubMed Web of Science ®Google Scholar
• Ataie G, Safarian S, Divsalar A, Saboury AA, Moosavi-Movahedi AA, Ranjbar B, Cristalli G, Mardanian S. Kinetic and structural analysis of adenosine deaminase upon interaction with acetaminophen. J Enz Inhib Med Chem 2004; 19: 71–78
   PubMed Web of Science ®Google Scholar
• Saboury AA, Bagheri S, Ataie G, Moosavi-Movahedi AA, Hakimelahi GH, Cristalli G, Mardanian SA. Thermodynamic and kinetic study on the inhibition of adenosine deaminase by theobromine Asian. J Chem 2005; 17: 233–239
   Web of Science ®Google Scholar
• Saboury AA. A simple method for determination of binding isotherm by isothermal titration calorimetry and its application to the interaction between Cu2+ and myelin basic protein. J Thermal Anal Cal 2004; 77: 997–1004
   Web of Science ®Google Scholar
• Ataie G, Moosavi-Movahedi AA, Saboury AA, Hakimelahi GH, Hwu JR, Tsay SC. Enthalpy and enzyme activity of modified histidine residues of adenosine deaminase and diethyl pyrocarbonate complexes Int. J Biol Macromol 2000; 27: 29–33
   PubMed Web of Science ®Google Scholar
• Terasaka T, Kinoshita T, Kuno M, Nakanishi I. A highly potent non-nucleoside adenosine deaminase inhibitor: Efficient drug discovery by intentional lead hybridization. J Am Chem Soc 2004; 126: 34–35
   PubMed Web of Science ®Google Scholar
• Terasaka T, Okumura H, Tsuji K, Kato T, Nakanishi I, Kinoshita T, Kato Y, Kuno M, Seki N, Naoe Y, Inoue T, Tanaka K, Nakamura K. Structure-based design and synthesis of non-nucleoside, potent and orally bioavailable adenosine deaminase inhibitors. J Med Chem 2004; 47: 2728–2731
   PubMed Web of Science ®Google Scholar
• Marron TJ, Straatsma TP, Briggs JM, Wilson DK, Quicho FA, McCammon JA. Theoretical study of inhibition of adenosine deaminase by 8R-Coformycin and 8R-Deoxycoformycin. J Med Chem 1996; 39: 277–284
   PubMed Web of Science ®Google Scholar
• Moosavi-Movahedi AA, Safarian S, Hakimelahi GH, Ataei G, Ajloo D, Panjehpour S, Riahi S, Mousavi MF, Mardanyan S. QSAR analysis for ADA upon interaction with a series of adenine derivatives as inhibitors nucleosides. Nucleotides & Nucleic acids. 2004; 3: 613–624
   Web of Science ®Google Scholar
• Kaplan NO. Meth Enzymol. Academic Press, New York 1955; Vol. 2: 473–480
   Google Scholar
• Brady TG, O'sullivan W. The effect of pH, urea and guanidine on adenosine deaminase isolated from bovine mucosa Biochim. Biophys Acta 1967; 132: 127–137
   PubMed Web of Science ®Google Scholar
• Todeschini R, Consonni V, Mauri A, Pavan M, Dragon-3.0
   Google Scholar
• Todeschini R, Consonni V. Various molecular descriptors Handbook of Molecular descriptors. Wiley-VCH, Weinheim, Germany 2000.
   Google Scholar
• Gibson S, McGuire R, Rees DC. Principal components describing biological activities and molecular diversity of heterocyclic aromatic ring fragments. J Med Chem 1996; 39: 4065–4072
   PubMed Web of Science ®Google Scholar
• Gupta SP. Quantitative structure-activity relationship studies on local anesthetics. Chem Rev 1991; 91: 1109–1118
   Web of Science ®Google Scholar
• Hadjipavlou-Litina D, Hansch C. Quantitative structure-activity relationship of the benzodiazepines. Chem Rev 1994; 94: 1493–1505
   Web of Science ®Google Scholar
• Zhang L, Gao H, Hansch C, Salassie CD. Molecular orbital parameters and comparative QSAR in the analysis of phenol toxicity to leukemia cells. J Chem Soc Perkin Trans 1998; 2: 2553–2556
   Google Scholar
• Ghadermarzi AA, Saboury AA, Moosavi-Movahedi AA. A microcalorimetry and spectroscopy study on the interaction of catalase with cyanide ion. Polish J Chem 1998; 72: 2024–2029
   Google Scholar